日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Tokenizing loops of antibodies

抗体环的标记化

期刊:MAbs
影响因子:7.3
doi:10.1080/19420862.2026.2645271
Fang, Ada; Alberstein, Robert G; Kelow, Simon; Dreyer, Frédéric A
发表日期：2026
文献求助 收藏

Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing

早期发病肾细胞癌患者接受生殖系检测时，DNA复制和修复基因的候选变异

期刊:BMC Genomics
影响因子:3.7
doi:10.1186/s12864-023-09310-8
Demidova, Elena V; Serebriiskii, Ilya G; Vlasenkova, Ramilia; Kelow, Simon; Andrake, Mark D; Hartman, Tiffiney R; Kent, Tatiana; Virtucio, James; Rosen, Gail L; Pomerantz, Richard T; Dunbrack, Roland L Jr; Golemis, Erica A; Hall, Michael J; Chen, David Y T; Daly, Mary B; Arora, Sanjeevani
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2023
文献求助 收藏

Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing

更正：早期发病肾细胞癌患者接受生殖系检测时，DNA复制和修复基因中的候选变异

期刊:BMC Genomics
影响因子:3.7
doi:10.1186/s12864-023-09486-z
Demidova, Elena V; Serebriiskii, Ilya G; Vlasenkova, Ramilia; Kelow, Simon; Andrake, Mark D; Hartman, Tiffiney R; Kent, Tatiana; Virtucio, James; Rosen, Gail L; Pomerantz, Richard T; Dunbrack, Roland L Jr; Golemis, Erica A; Hall, Michael J; Chen, David Y T; Daly, Mary B; Arora, Sanjeevani
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2023
文献求助 收藏

Corrigendum to "Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus" [Heliyon 9(4) (April 2023) e15032]

对“利用 RosettaAntibodyDesign (RAbD) 对抗体 80R 进行特异性转换，计算设计针对多种 SARS-CoV-2 变体的纳摩尔结合抗体，从而获得可用于新型 SARS-CoV-2 病毒的潜在通用治疗性抗体”的更正 [Heliyon 9(4) (2023 年 4 月) e15032]

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2023.e17901
Hernandez, Nancy E; Jankowski, Wojciech; Frick, Rahel; Kelow, Simon P; Lubin, Joseph H; Simhadri, Vijaya; Adolf-Bryfogle, Jared; Khare, Sagar D; Dunbrack, Roland L Jr; Gray, Jeffrey J; Sauna, Zuben E
微生物学
SARS-CoV-2
发表日期：2023
文献求助 收藏

Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus

通过使用 RosettaAntibodyDesign (RAbD) 设计抗体 80R 的特异性开关，计算设计针对多种 SARS-CoV-2 变体的纳摩尔结合抗体，从而为新型 SARS-CoV-2 病毒提供潜在的可推广治疗性抗体

期刊:Heliyon
影响因子:3.4
doi:10.1016/j.heliyon.2023.e15032
Nancy E Hernandez, Wojciech Jankowski, Rahel Frick, Simon P Kelow, Joseph H Lubin, Vijaya Simhadri, Jared Adolf-Bryfogle, Sagar D Khare, Roland L Dunbrack Jr, Jeffrey J Gray, Zuben E Sauna
代谢
免疫
微生物学
心血管
新冠
发表日期：2023
文献求助 收藏

Hiding in plain sight: structure and sequence analysis reveals the importance of the antibody DE loop for antibody-antigen binding

隐藏在眼皮底下：结构和序列分析揭示抗体DE环对抗体-抗原结合的重要性

期刊:MAbs
影响因子:7.3
doi:10.1080/19420862.2020.1840005
Kelow, Simon P; Adolf-Bryfogle, Jared; Dunbrack, Roland L
发表日期：2020
文献求助 收藏

Contribution of an unusual CDR2 element of a single domain antibody in ricin toxin binding affinity and neutralizing activity

单域抗体中不寻常的CDR2元件对蓖麻毒素结合亲和力和中和活性的贡献

期刊:Protein Engineering Design & Selection
影响因子:3.4
doi:10.1093/protein/gzy022
Rudolph, Michael J; Vance, David J; Kelow, Simon; Angalakurthi, Siva Krishna; Nguyen, Sophie; Davis, Simon A; Rong, Yinghui; Middaugh, C Russell; Weis, David D; Dunbrack, Roland Jr; Karanicolas, John; Mantis, Nicholas J
CDR2
发表日期：2018
文献求助 收藏